0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Proton Pump Inhibitors for Gastric Acid Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-4K15323
Home | Market Reports | Health| Health Conditions
Global Proton Pump Inhibitors for Gastric Acid Therapy Market Insights Forecast to 2029
BUY CHAPTERS

Proton Pump Inhibitors for Gastric Acid Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-4K15323
Report
December 2024
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Proton Pump Inhibitors for Gastric Acid Therapy - Market Size

The global market for Proton Pump Inhibitors for Gastric Acid Therapy was estimated to be worth US$ 11790 million in 2023 and is forecast to a readjusted size of US$ 9299.2 million by 2030 with a CAGR of -3.2% during the forecast period 2024-2030

Proton Pump Inhibitors for Gastric Acid Therapy - Market

Proton Pump Inhibitors for Gastric Acid Therapy - Market

Proton pump inhibitors (PPIs) reduce the production of acid by blocking the enzyme in the wall of the stomach that produces acid. Acid is necessary for the formation of most ulcers in the esophagus, stomach, and duodenum, and the reduction of acid with PPIs prevents ulcers and allows any ulcers that exist in the esophagus, stomach, and duodenum to heal.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Proton Pump Inhibitors for Gastric Acid Therapy, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Proton Pump Inhibitors for Gastric Acid Therapy by region & country, by Type, and by Application.
The Proton Pump Inhibitors for Gastric Acid Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Proton Pump Inhibitors for Gastric Acid Therapy.
Market Segmentation

Scope of Proton Pump Inhibitors for Gastric Acid Therapy - Market Report

Report Metric Details
Report Name Proton Pump Inhibitors for Gastric Acid Therapy - Market
Forecasted market size in 2030 US$ 9299.2 million
Forecasted years 2024 - 2030
Segment by Type:
  • Dexlansoprazole
  • Esomeprazole
  • Lansoprazole
  • Omeprazole
  • Pantoprazole
  • Rabeprazole
Segment by Application
  • Hospital Pharmacy
  • Retail Pharmacy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda, Pfizer, AstraZeneca, Bayer, Sun Pharma, Teva, Eisai Co., Mylan, AOSAIKANG Pharma, Luoxin Pharma, LIVZON, Eastchina Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Proton Pump Inhibitors for Gastric Acid Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Proton Pump Inhibitors for Gastric Acid Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Proton Pump Inhibitors for Gastric Acid Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Proton Pump Inhibitors for Gastric Acid Therapy - Market size in 2030?

Ans: The Proton Pump Inhibitors for Gastric Acid Therapy - Market size in 2030 will be US$ 9299.2 million.

Who are the main players in the Proton Pump Inhibitors for Gastric Acid Therapy - Market report?

Ans: The main players in the Proton Pump Inhibitors for Gastric Acid Therapy - Market are Takeda, Pfizer, AstraZeneca, Bayer, Sun Pharma, Teva, Eisai Co., Mylan, AOSAIKANG Pharma, Luoxin Pharma, LIVZON, Eastchina Pharma

What are the Application segmentation covered in the Proton Pump Inhibitors for Gastric Acid Therapy - Market report?

Ans: The Applications covered in the Proton Pump Inhibitors for Gastric Acid Therapy - Market report are Hospital Pharmacy, Retail Pharmacy, Other

What are the Type segmentation covered in the Proton Pump Inhibitors for Gastric Acid Therapy - Market report?

Ans: The Types covered in the Proton Pump Inhibitors for Gastric Acid Therapy - Market report are Dexlansoprazole, Esomeprazole, Lansoprazole, Omeprazole, Pantoprazole, Rabeprazole

1 Market Overview
1.1 Proton Pump Inhibitors for Gastric Acid Therapy Product Introduction
1.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Market Size Forecast
1.2.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value (2019-2030)
1.2.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume (2019-2030)
1.2.3 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Price (2019-2030)
1.3 Proton Pump Inhibitors for Gastric Acid Therapy Market Trends & Drivers
1.3.1 Proton Pump Inhibitors for Gastric Acid Therapy Industry Trends
1.3.2 Proton Pump Inhibitors for Gastric Acid Therapy Market Drivers & Opportunity
1.3.3 Proton Pump Inhibitors for Gastric Acid Therapy Market Challenges
1.3.4 Proton Pump Inhibitors for Gastric Acid Therapy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Players Revenue Ranking (2023)
2.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue by Company (2019-2024)
2.3 Global Proton Pump Inhibitors for Gastric Acid Therapy Players Sales Volume Ranking (2023)
2.4 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Company Players (2019-2024)
2.5 Global Proton Pump Inhibitors for Gastric Acid Therapy Average Price by Company (2019-2024)
2.6 Key Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Proton Pump Inhibitors for Gastric Acid Therapy
2.9 Proton Pump Inhibitors for Gastric Acid Therapy Market Competitive Analysis
2.9.1 Proton Pump Inhibitors for Gastric Acid Therapy Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Proton Pump Inhibitors for Gastric Acid Therapy Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proton Pump Inhibitors for Gastric Acid Therapy as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Dexlansoprazole
3.1.2 Esomeprazole
3.1.3 Lansoprazole
3.1.4 Omeprazole
3.1.5 Pantoprazole
3.1.6 Rabeprazole
3.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type
3.2.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, by Type (2019-2030)
3.2.3 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, by Type (%) (2019-2030)
3.3 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Type
3.3.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume, by Type (2019-2030)
3.3.3 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume, by Type (%) (2019-2030)
3.4 Global Proton Pump Inhibitors for Gastric Acid Therapy Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Other
4.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application
4.2.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, by Application (2019-2030)
4.2.3 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, by Application (%) (2019-2030)
4.3 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Application
4.3.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume, by Application (2019-2030)
4.3.3 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume, by Application (%) (2019-2030)
4.4 Global Proton Pump Inhibitors for Gastric Acid Therapy Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Region
5.1.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Region (2019-2024)
5.1.3 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Region (2025-2030)
5.1.4 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Region (%), (2019-2030)
5.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Region
5.2.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Region (2019-2024)
5.2.3 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Region (2025-2030)
5.2.4 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Region (%), (2019-2030)
5.3 Global Proton Pump Inhibitors for Gastric Acid Therapy Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, 2019-2030
5.4.2 North America Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, 2019-2030
5.5.2 Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, 2019-2030
5.6.2 Asia Pacific Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, 2019-2030
5.7.2 South America Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, 2019-2030
5.8.2 Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Proton Pump Inhibitors for Gastric Acid Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Proton Pump Inhibitors for Gastric Acid Therapy Sales Value
6.2.1 Key Countries/Regions Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, 2019-2030
6.2.2 Key Countries/Regions Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, 2019-2030
6.3.2 United States Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, 2019-2030
6.4.2 Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, 2019-2030
6.5.2 China Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type (%), 2023 VS 2030
6.5.3 China Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, 2019-2030
6.6.2 Japan Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, 2019-2030
6.7.2 South Korea Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, 2019-2030
6.8.2 Southeast Asia Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, 2019-2030
6.9.2 India Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type (%), 2023 VS 2030
6.9.3 India Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Takeda
7.1.1 Takeda Company Information
7.1.2 Takeda Introduction and Business Overview
7.1.3 Takeda Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Takeda Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
7.1.5 Takeda Recent Development
7.2 Pfizer
7.2.1 Pfizer Company Information
7.2.2 Pfizer Introduction and Business Overview
7.2.3 Pfizer Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Pfizer Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
7.2.5 Pfizer Recent Development
7.3 AstraZeneca
7.3.1 AstraZeneca Company Information
7.3.2 AstraZeneca Introduction and Business Overview
7.3.3 AstraZeneca Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue and Gross Margin (2019-2024)
7.3.4 AstraZeneca Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
7.3.5 AstraZeneca Recent Development
7.4 Bayer
7.4.1 Bayer Company Information
7.4.2 Bayer Introduction and Business Overview
7.4.3 Bayer Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Bayer Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
7.4.5 Bayer Recent Development
7.5 Sun Pharma
7.5.1 Sun Pharma Company Information
7.5.2 Sun Pharma Introduction and Business Overview
7.5.3 Sun Pharma Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Sun Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
7.5.5 Sun Pharma Recent Development
7.6 Teva
7.6.1 Teva Company Information
7.6.2 Teva Introduction and Business Overview
7.6.3 Teva Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Teva Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
7.6.5 Teva Recent Development
7.7 Eisai Co.
7.7.1 Eisai Co. Company Information
7.7.2 Eisai Co. Introduction and Business Overview
7.7.3 Eisai Co. Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Eisai Co. Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
7.7.5 Eisai Co. Recent Development
7.8 Mylan
7.8.1 Mylan Company Information
7.8.2 Mylan Introduction and Business Overview
7.8.3 Mylan Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Mylan Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
7.8.5 Mylan Recent Development
7.9 AOSAIKANG Pharma
7.9.1 AOSAIKANG Pharma Company Information
7.9.2 AOSAIKANG Pharma Introduction and Business Overview
7.9.3 AOSAIKANG Pharma Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue and Gross Margin (2019-2024)
7.9.4 AOSAIKANG Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
7.9.5 AOSAIKANG Pharma Recent Development
7.10 Luoxin Pharma
7.10.1 Luoxin Pharma Company Information
7.10.2 Luoxin Pharma Introduction and Business Overview
7.10.3 Luoxin Pharma Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Luoxin Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
7.10.5 Luoxin Pharma Recent Development
7.11 LIVZON
7.11.1 LIVZON Company Information
7.11.2 LIVZON Introduction and Business Overview
7.11.3 LIVZON Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue and Gross Margin (2019-2024)
7.11.4 LIVZON Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
7.11.5 LIVZON Recent Development
7.12 Eastchina Pharma
7.12.1 Eastchina Pharma Company Information
7.12.2 Eastchina Pharma Introduction and Business Overview
7.12.3 Eastchina Pharma Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Eastchina Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
7.12.5 Eastchina Pharma Recent Development
8 Industry Chain Analysis
8.1 Proton Pump Inhibitors for Gastric Acid Therapy Industrial Chain
8.2 Proton Pump Inhibitors for Gastric Acid Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Proton Pump Inhibitors for Gastric Acid Therapy Sales Model
8.5.2 Sales Channel
8.5.3 Proton Pump Inhibitors for Gastric Acid Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Proton Pump Inhibitors for Gastric Acid Therapy Market Trends
    Table 2. Proton Pump Inhibitors for Gastric Acid Therapy Market Drivers & Opportunity
    Table 3. Proton Pump Inhibitors for Gastric Acid Therapy Market Challenges
    Table 4. Proton Pump Inhibitors for Gastric Acid Therapy Market Restraints
    Table 5. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Company (2019-2024)
    Table 7. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Proton Pump Inhibitors for Gastric Acid Therapy Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Proton Pump Inhibitors for Gastric Acid Therapy
    Table 13. Global Proton Pump Inhibitors for Gastric Acid Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proton Pump Inhibitors for Gastric Acid Therapy as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Proton Pump Inhibitors for Gastric Acid Therapy Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Proton Pump Inhibitors for Gastric Acid Therapy Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Proton Pump Inhibitors for Gastric Acid Therapy Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Proton Pump Inhibitors for Gastric Acid Therapy Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Region (2019-2024) & (%)
    Table 44. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Region (2025-2030) & (%)
    Table 45. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Proton Pump Inhibitors for Gastric Acid Therapy Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Proton Pump Inhibitors for Gastric Acid Therapy Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Proton Pump Inhibitors for Gastric Acid Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume, (2025-2030) & (K Units)
    Table 57. Takeda Company Information
    Table 58. Takeda Introduction and Business Overview
    Table 59. Takeda Proton Pump Inhibitors for Gastric Acid Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Takeda Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
    Table 61. Takeda Recent Development
    Table 62. Pfizer Company Information
    Table 63. Pfizer Introduction and Business Overview
    Table 64. Pfizer Proton Pump Inhibitors for Gastric Acid Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Pfizer Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
    Table 66. Pfizer Recent Development
    Table 67. AstraZeneca Company Information
    Table 68. AstraZeneca Introduction and Business Overview
    Table 69. AstraZeneca Proton Pump Inhibitors for Gastric Acid Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. AstraZeneca Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
    Table 71. AstraZeneca Recent Development
    Table 72. Bayer Company Information
    Table 73. Bayer Introduction and Business Overview
    Table 74. Bayer Proton Pump Inhibitors for Gastric Acid Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Bayer Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
    Table 76. Bayer Recent Development
    Table 77. Sun Pharma Company Information
    Table 78. Sun Pharma Introduction and Business Overview
    Table 79. Sun Pharma Proton Pump Inhibitors for Gastric Acid Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Sun Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
    Table 81. Sun Pharma Recent Development
    Table 82. Teva Company Information
    Table 83. Teva Introduction and Business Overview
    Table 84. Teva Proton Pump Inhibitors for Gastric Acid Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Teva Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
    Table 86. Teva Recent Development
    Table 87. Eisai Co. Company Information
    Table 88. Eisai Co. Introduction and Business Overview
    Table 89. Eisai Co. Proton Pump Inhibitors for Gastric Acid Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Eisai Co. Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
    Table 91. Eisai Co. Recent Development
    Table 92. Mylan Company Information
    Table 93. Mylan Introduction and Business Overview
    Table 94. Mylan Proton Pump Inhibitors for Gastric Acid Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Mylan Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
    Table 96. Mylan Recent Development
    Table 97. AOSAIKANG Pharma Company Information
    Table 98. AOSAIKANG Pharma Introduction and Business Overview
    Table 99. AOSAIKANG Pharma Proton Pump Inhibitors for Gastric Acid Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. AOSAIKANG Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
    Table 101. AOSAIKANG Pharma Recent Development
    Table 102. Luoxin Pharma Company Information
    Table 103. Luoxin Pharma Introduction and Business Overview
    Table 104. Luoxin Pharma Proton Pump Inhibitors for Gastric Acid Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Luoxin Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
    Table 106. Luoxin Pharma Recent Development
    Table 107. LIVZON Company Information
    Table 108. LIVZON Introduction and Business Overview
    Table 109. LIVZON Proton Pump Inhibitors for Gastric Acid Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. LIVZON Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
    Table 111. LIVZON Recent Development
    Table 112. Eastchina Pharma Company Information
    Table 113. Eastchina Pharma Introduction and Business Overview
    Table 114. Eastchina Pharma Proton Pump Inhibitors for Gastric Acid Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Eastchina Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product Offerings
    Table 116. Eastchina Pharma Recent Development
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Proton Pump Inhibitors for Gastric Acid Therapy Downstream Customers
    Table 120. Proton Pump Inhibitors for Gastric Acid Therapy Distributors List
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Proton Pump Inhibitors for Gastric Acid Therapy Product Picture
    Figure 2. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Proton Pump Inhibitors for Gastric Acid Therapy Report Years Considered
    Figure 7. Global Proton Pump Inhibitors for Gastric Acid Therapy Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Proton Pump Inhibitors for Gastric Acid Therapy Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Proton Pump Inhibitors for Gastric Acid Therapy Revenue in 2023
    Figure 10. Proton Pump Inhibitors for Gastric Acid Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Dexlansoprazole Picture
    Figure 12. Esomeprazole Picture
    Figure 13. Lansoprazole Picture
    Figure 14. Omeprazole Picture
    Figure 15. Pantoprazole Picture
    Figure 16. Rabeprazole Picture
    Figure 17. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value Market Share by Type, 2023 & 2030
    Figure 19. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 20. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume Market Share by Type, 2023 & 2030
    Figure 21. Global Proton Pump Inhibitors for Gastric Acid Therapy Price by Type (2019-2030) & (US$/Unit)
    Figure 22. Product Picture of Hospital Pharmacy
    Figure 23. Product Picture of Retail Pharmacy
    Figure 24. Product Picture of Other
    Figure 25. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 26. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Value Market Share by Application, 2023 & 2030
    Figure 27. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 28. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume Market Share by Application, 2023 & 2030
    Figure 29. Global Proton Pump Inhibitors for Gastric Acid Therapy Price by Application (2019-2030) & (US$/Unit)
    Figure 30. North America Proton Pump Inhibitors for Gastric Acid Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 31. North America Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 32. Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 33. Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 34. Asia Pacific Proton Pump Inhibitors for Gastric Acid Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 36. South America Proton Pump Inhibitors for Gastric Acid Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 37. South America Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 38. Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 39. Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 40. Key Countries/Regions Proton Pump Inhibitors for Gastric Acid Therapy Sales Value (%), (2019-2030)
    Figure 41. Key Countries/Regions Proton Pump Inhibitors for Gastric Acid Therapy Sales Volume (%), (2019-2030)
    Figure 42. United States Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 43. United States Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 44. United States Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 45. Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 47. Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 48. China Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 49. China Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 50. China Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 51. Japan Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 52. Japan Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 53. Japan Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 54. South Korea Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 55. South Korea Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 56. South Korea Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 57. Southeast Asia Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 58. Southeast Asia Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 59. Southeast Asia Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 60. India Proton Pump Inhibitors for Gastric Acid Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 61. India Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 62. India Proton Pump Inhibitors for Gastric Acid Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 63. Proton Pump Inhibitors for Gastric Acid Therapy Industrial Chain
    Figure 64. Proton Pump Inhibitors for Gastric Acid Therapy Manufacturing Cost Structure
    Figure 65. Channels of Distribution (Direct Sales, and Distribution)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Clotting Factors Ⅷ Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-21S8513
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Rare Genetic Disease Diagnosis Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-17L15214
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Endoscopes for Otology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-19V14797
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Immunotherapy Drugs for Neuroblastoma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-39R14639
Thu Dec 12 00:00:00 UTC 2024

Add to Cart